Cerebral Small Vessel Diseases Clinical Trial
— ESCAPE-SVDOfficial title:
Effects of Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation, Blood Pressure and Heart Rate Variability in Patients With Cerebral Small Vessel Disease
The purpose of this study is to determine effects of remote ischemic conditioning on dynamic cerebral autoregulation, blood pressure and heart rate variability in patients with cerebral small vessel disease.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | October 31, 2025 |
Est. primary completion date | July 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - 1) Regardless of age, sex; - 2) Patients are diagnosed with cerebral small vessel disease, and neuroimaging shows new subcortical lacunar infarction (in line with one of the following): ? MRI examination Diffusion-weighted imaging (DWI) phase shows high signal intensity [Apparent Diffusion Coefficient (ADC) diffusion restriction] lesions < 20 mm diameter in subcortical, basal ganglia or brainstem , with or without corresponding clinical symptoms; ? With new clinical symptoms, MRI examination FLAIR sequence shows corresponding FLAIR high signal intensity lesions [diameter < 20 mm]) in subcortical, basal ganglia or pons; - 3) Remote ischemic conditioning can be started within 7 days from onset; - 4) Willing to participate and sign the informed consent. Exclusion Criteria: - 1) Vascular stenosis > 50% by Transcranial Doppler (TCD); - 2) Previous history of intracranial hemorrhage or major bleeding in other parts of the body; - 3) Previous history of atrial fibrillation or myocardial infarction within 6 months; - 4) Moyamoya disease or hereditary cerebral small vessel disease, such as mitochondrial encephalopathy, CADASIL or Fabry; - 5) The patients who had clear non-vascular white matter lesions, such as multiple sclerosis, adult white matter dysplasia, metabolic encephalopathy; - 6) Severe hepatic and renal diseases, cancer or other major diseases related to medical and surgical procedures; - 7) The patients who had the contraindication of remote ischemic conditioning treatment, such as severe soft tissue injury, fracture or vascular injury in the upper limb; Acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc; - 8) Significant coagulation abnormalities; - 9) Pregnant or lactating women; - 10) The patients with disturbance of consciousness or agitation who cannot cooperate to dynamic cerebral autoregulation monitoring or beat-to-beat blood pressure monitoring; - 11) Previous remote ischemic conditioning therapy or similar treatment; - 12) Unwilling to be followed up or treated for poor compliance; - 13) He/She is participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to admission; - 14) Other conditions that the researchers think are not suitable for the group. |
Country | Name | City | State |
---|---|---|---|
China | The First Hospital of Jilin University | Changchun | Jilin |
Lead Sponsor | Collaborator |
---|---|
Yi Yang |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Phase Difference(PD) in Degree | PD is a dynamic cerebral auto-regulation parameter derived from transfer function analysis. | within 7 days of RIC | |
Primary | Differences of blood pressure variability (BPV) in Degree after in-hospital remote ischemic conditioning finished between two groups | BPV is defined as blood pressure oscillations in relation to the mean values. | within 7 days of RIC | |
Primary | Differences of heart rate variability (HRV) in Degree after in-hospital remote ischemic conditioning finished between two groups | HRV is defined as heart rate oscillations in relation to the mean values. | within 7 days of RIC | |
Secondary | Differences of BPV in Degree after 3-4 days remote ischemic conditioning treatment between two groups | BPV is defined as blood pressure oscillations in relation to the mean values. | 3-4 days after RIC | |
Secondary | Differences of HRV in Degree after 3-4 days remote ischemic conditioning treatment between two groups | HRV is defined as heart rate oscillations in relation to the mean values. | 3-4 days after RIC | |
Secondary | PD in Degree | PD is a dynamic cerebral auto-regulation parameter derived from transfer function analysis. | 3-4 days after RIC | |
Secondary | Differences in modified Rankin Scale (mRS) Score between two groups | Modified Rankin Scale (mRS) Score ranged from 0 to 6, a low value represents a better outcome. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04041349 -
Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease
|
Phase 4 | |
Recruiting |
NCT04109963 -
Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment
|
Phase 2 | |
Not yet recruiting |
NCT06416371 -
Retinal Vessel Leakage in Cerebral Small Vessel Disease
|
||
Not yet recruiting |
NCT05967728 -
Testing of a System for Remote Ischemic Conditioning in Cerebral Small Vessel Disease and Pre-hospital Stroke Care
|
Phase 2 | |
Completed |
NCT05714813 -
Circuit Training and Retina
|
N/A | |
Not yet recruiting |
NCT06077305 -
A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke
|
||
Not yet recruiting |
NCT06061692 -
Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD)
|
Phase 4 | |
Recruiting |
NCT04962295 -
China Imaging-based Biobank of Cerebral Small Vessal Diseases
|
||
Completed |
NCT02801032 -
Effect of Tadalafil on Cerebral Large Arteries in Stroke
|
Phase 2 | |
Not yet recruiting |
NCT05594966 -
Neuroimaging Combining Biomarkers for Identifying Long-term Cognitive Dysfunction and Delirium
|
||
Terminated |
NCT02890888 -
Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease
|
N/A | |
Recruiting |
NCT04318119 -
Cerebral Small Vessel Disease Registry Study
|
||
Recruiting |
NCT03906123 -
The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia
|
N/A | |
Recruiting |
NCT05306834 -
Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
|
N/A | |
Not yet recruiting |
NCT05583266 -
Efficacy of Pentoxifylline on Cerebrovascular Function in Patients With Cerebral Small Vessel Disease(PERFORM)
|
Phase 4 | |
Recruiting |
NCT05173896 -
Improving Cerebral Blood Flow and Cognition in Patients With Cerebral Small Vessel Disease. The ETLAS-2 Trial
|
Phase 2 | |
Recruiting |
NCT01819441 -
Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
|
Phase 4 | |
Recruiting |
NCT01688505 -
Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function
|
N/A | |
Recruiting |
NCT04330222 -
Cambridge 7 Tesla Cerebral Small Vessel Disease Study
|
||
Recruiting |
NCT04298866 -
White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI
|
N/A |